Skip to main content

Adverse Outcome Pathway on aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2

Working paper

More info

Authors
Jon Doering, Markus Hecker, Daniel L. Villeneuve, Xiaowei Zhang
OECD Series on Adverse Outcome Pathways

Cite this content as:

Doering, J. et al. (2019), “Adverse Outcome Pathway on aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2”, OECD Series on Adverse Outcome Pathways, No. 12, OECD Publishing, Paris, https://doi.org/10.1787/bd46b538-en.
Go to top